Unknown

Dataset Information

0

Regulation of T cell afferent lymphatic migration by targeting LT?R-mediated non-classical NF?B signaling.


ABSTRACT: Lymphotoxin-beta receptor (LT?R) signaling in lymphatic endothelial cells (LEC) regulates leukocyte afferent lymphatic transendothelial migration (TEM). The function of individual signaling pathways for different leukocyte subsets is currently unknown. Here, we show that LT?R signals predominantly via the constitutive and ligand-driven non-classical NIK pathway. Targeting LT?R-NIK by an LT?R-derived decoy peptide (nciLT) suppresses the production of chemokines CCL21 and CXCL12, and enhances the expression of classical NF?B-driven VCAM-1 and integrin ?4 to retain T cells on LEC and precludes T cell and dendritic cell TEM. nciLT inhibits contact hypersensitivity (CHS) at both the sensitization and elicitation stages, likely by inhibiting leukocyte migration. By contrast, targeting LT?R-classical NF?B signaling during the elicitation and resolution stages attenuates CHS, possibly by promoting leukocyte egress. These findings demonstrate the importance of LT?R signaling in leukocyte migration and LEC and lymphatic vessel function, and show that antagonist peptides may serve as lead compounds for therapeutic applications.

SUBMITTER: Piao W 

PROVIDER: S-EPMC6070541 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of T cell afferent lymphatic migration by targeting LTβR-mediated non-classical NFκB signaling.

Piao Wenji W   Xiong Yanbao Y   Famulski Konrad K   Brinkman C Colin CC   Li Lushen L   Toney Nicholas N   Wagner Chelsea C   Saxena Vikas V   Simon Thomas T   Bromberg Jonathan S JS  

Nature communications 20180801 1


Lymphotoxin-beta receptor (LTβR) signaling in lymphatic endothelial cells (LEC) regulates leukocyte afferent lymphatic transendothelial migration (TEM). The function of individual signaling pathways for different leukocyte subsets is currently unknown. Here, we show that LTβR signals predominantly via the constitutive and ligand-driven non-classical NIK pathway. Targeting LTβR-NIK by an LTβR-derived decoy peptide (nciLT) suppresses the production of chemokines CCL21 and CXCL12, and enhances the  ...[more]

Similar Datasets

| S-EPMC4919545 | biostudies-literature
| S-EPMC4779695 | biostudies-literature
| S-EPMC3960999 | biostudies-literature
| S-EPMC3952712 | biostudies-literature
| S-EPMC2770835 | biostudies-literature
| S-EPMC6744614 | biostudies-literature
| S-EPMC6362934 | biostudies-literature
| S-EPMC6934272 | biostudies-literature
| S-EPMC8540133 | biostudies-literature
| S-EPMC3209329 | biostudies-literature